Global Dextrose Injection Market Size, Status and Forecast 2021-2027

Dextrose is also called as glucose as they are chemically identical. It plays a vital role in providing energy to body cells. Dextrose Injection is a non-pyrogenic and sterile solution for caloric supply and fluid replenishment by a single dose. Route of administration of dextrose injection is intravenous i.e. into the vein. Dosage of dextrose injection depends upon weight, age, and clinical condition of the patient. Dextrose 5% in water is injected into the vein to replace lost fluids and also provide carbohydrates to the body. Dextrose 5% in water is also used to treat hypoglycemia (low blood sugar), insulin shock and dehydration (fluid loss). Dextrose is a carbohydrate which is a part of nutrition. Dextrose solution along with amino acids and fats provide nutrition the body. This is called as total parental nutrition. Hyperkalemia is a condition in which potassium levels are high. Dextrose solution (50%) is administered to person suffering from hyperkalemia.
Increasing number of launches pertaining to novel dextrose injection products by key players in the market is expected to drive market growth. For instance in 2018, SteriMAx Inc., engaged in production, development, marketing and distribution of essential hospital and retail pharmacy products, launched new drug Bupivacaine Hydrochloride in 8.25% dextrose injection indicated for spinal anesthesia. It is a subarachnoid injection (spinal block).

Market Analysis and Insights: Global Dextrose Injection Market
The global Dextrose Injection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dextrose Injection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dextrose Injection market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dextrose Injection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dextrose Injection market.

Global Dextrose Injection Scope and Market Size
Dextrose Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dextrose Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection

Segment by Application
First-Aid Treatment
Sports
Trophotherapy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Amphastar
ChanGee
Seqirus
Baxter
Shandong Qidu Pharmaceutical
Sanctus Drugs & Pharmaceuticals
Mountainside Medical
Hospira